{"id":"https://openalex.org/W2155459657","doi":"https://doi.org/10.1016/j.ejca.2008.10.039","title":"Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial","display_name":"Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial","publication_year":2008,"publication_date":"2008-12-27","ids":{"openalex":"https://openalex.org/W2155459657","doi":"https://doi.org/10.1016/j.ejca.2008.10.039","mag":"2155459657","pmid":"https://pubmed.ncbi.nlm.nih.gov/19101137"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejca.2008.10.039","doi":"https://doi.org/10.1016/j.ejca.2008.10.039","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejca.2008.10.039","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045084441","display_name":"Heike Richly","orcid":"https://orcid.org/0000-0001-6081-0978","observed_orcids":["https://orcid.org/0000-0001-6081-0978"]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"H. Richly","raw_affiliation_strings":["Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany. heike.richly@uni-due.de","Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany. heike.richly@uni-due.de","institution_ids":["https://openalex.org/I62318514"]},{"raw_affiliation_string":"Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040836871","display_name":"Beate S. Schultheis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"B. Schultheis","raw_affiliation_strings":["Department of Hematology and Medical Oncology, University Medical School of Bochum (Marienhospital Herne), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, University Medical School of Bochum (Marienhospital Herne), Germany","institution_ids":["https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020875104","display_name":"Iren\u00e4\ufeffus A. Adamietz","orcid":"https://orcid.org/0000-0002-7747-7259","observed_orcids":["https://orcid.org/0000-0002-7747-7259"]},"institutions":[{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"I.A. Adamietz","raw_affiliation_strings":["Department of Radiotherapy, University Medical School of Bochum (Marienhospital Herne), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, University Medical School of Bochum (Marienhospital Herne), Germany","institution_ids":["https://openalex.org/I4210088550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056058370","display_name":"Petra Kupsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P. Kupsch","raw_affiliation_strings":["Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020874078","display_name":"Matthias Grubert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Grubert","raw_affiliation_strings":["Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112066590","display_name":"Ralf Axel Hilger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R.A. Hilger","raw_affiliation_strings":["Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Cancer Research, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060329640","display_name":"Matthias Ludwig","orcid":"https://orcid.org/0009-0009-4586-8616","observed_orcids":["https://orcid.org/0009-0009-4586-8616"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Ludwig","raw_affiliation_strings":["Bayer Schering Pharma, Elberfeld, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Schering Pharma, Elberfeld, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025172712","display_name":"Erich Brendel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"E. Brendel","raw_affiliation_strings":["Bayer Schering Pharma, Elberfeld, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Schering Pharma, Elberfeld, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111696351","display_name":"O. Christensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O. Christensen","raw_affiliation_strings":["Bayer HealthCare Pharmaceuticals, Montville, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare Pharmaceuticals, Montville, NJ, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018436714","display_name":"Dirk Strumberg","orcid":"https://orcid.org/0000-0001-7053-8365","observed_orcids":["https://orcid.org/0000-0001-7053-8365"]},"institutions":[{"id":"https://openalex.org/I4210088550","display_name":"Universit\u00e4tsklinik Marien Hospital Herne","ror":"https://ror.org/004h6mc53","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D. Strumberg","raw_affiliation_strings":["Department of Hematology and Medical Oncology, University Medical School of Bochum (Marienhospital Herne), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, University Medical School of Bochum (Marienhospital Herne), Germany","institution_ids":["https://openalex.org/I4210088550"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5045084441"],"corresponding_institution_ids":["https://openalex.org/I62318514"],"apc_list":{"value":4270,"currency":"USD","value_usd":4270},"apc_paid":null,"fwci":6.3562,"has_fulltext":false,"cited_by_count":83,"citation_normalized_percentile":{"value":0.96521979,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"45","issue":"4","first_page":"579","last_page":"587"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/advanced-liver-cancer","display_name":"advanced liver cancer","score":0.7269999980926514},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.9670000076293945},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.722000002861023},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9350000023841858},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9933663606643677},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8857489824295044},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.8695759773254395},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8454020023345947},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5927821397781372},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5071938037872314},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4788082242012024},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.44286027550697327},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4335165023803711},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4194268584251404},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4087837338447571},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3424394726753235},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2933356761932373}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001557","descriptor_name":"Benzenesulfonates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001557","descriptor_name":"Benzenesulfonates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001557","descriptor_name":"Benzenesulfonates","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejca.2008.10.039","doi":"https://doi.org/10.1016/j.ejca.2008.10.039","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejca.2008.10.039","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:19101137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19101137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer (Oxford, England : 1990)","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1510894885","https://openalex.org/W1578736164","https://openalex.org/W1864201493","https://openalex.org/W1886323865","https://openalex.org/W1971529620","https://openalex.org/W1971837077","https://openalex.org/W1989151475","https://openalex.org/W1993099484","https://openalex.org/W1998832059","https://openalex.org/W1999966467","https://openalex.org/W2012582581","https://openalex.org/W2019961689","https://openalex.org/W2023545773","https://openalex.org/W2032743024","https://openalex.org/W2041330854","https://openalex.org/W2056527566","https://openalex.org/W2059148084","https://openalex.org/W2069828593","https://openalex.org/W2070396671","https://openalex.org/W2073595067","https://openalex.org/W2083509913","https://openalex.org/W2088629624","https://openalex.org/W2090686528","https://openalex.org/W2093083587","https://openalex.org/W2101031676","https://openalex.org/W2115754856","https://openalex.org/W2133559579","https://openalex.org/W2138822094","https://openalex.org/W2139579239","https://openalex.org/W2140765540","https://openalex.org/W2156871508","https://openalex.org/W2160036457","https://openalex.org/W2163486683","https://openalex.org/W2254418922","https://openalex.org/W2273386282","https://openalex.org/W2319257648","https://openalex.org/W2321119966","https://openalex.org/W2620640052","https://openalex.org/W3139763557"],"related_works":["https://openalex.org/W1965309017","https://openalex.org/W1983580988","https://openalex.org/W2063308959","https://openalex.org/W4241150488","https://openalex.org/W3081388035","https://openalex.org/W2085561668","https://openalex.org/W2972838475","https://openalex.org/W2590198115","https://openalex.org/W2972003656","https://openalex.org/W2051848895"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}